Cargando…
Translating known drivers of COVID-19 disease severity to design better SARS-CoV-2 vaccines
The SARS-CoV-2 pandemic has highlighted how an emergent disease can spread globally and how vaccines are once again the most important public health policy to combat infectious disease. Despite promising initial protection, the rise of new viral variants calls into question how effective current SAR...
Autores principales: | Pelletier, Adam N, Sekaly, Rafick P, Tomalka, Jeffrey A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664555/ https://www.ncbi.nlm.nih.gov/pubmed/34902803 http://dx.doi.org/10.1016/j.coviro.2021.11.012 |
Ejemplares similares
-
The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination
por: Tomalka, Jeffrey Alan, et al.
Publicado: (2021) -
A systems framework for vaccine design
por: Mooney, Michael, et al.
Publicado: (2013) -
The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?
por: Sekaly, Rafick-Pierre
Publicado: (2008) -
Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection
por: LATIF, MUHAMMAD BILAL, et al.
Publicado: (2022) -
Vaccination against SARS-CoV-2 and disease enhancement – knowns and unknowns
por: Zellweger, Raphaël M., et al.
Publicado: (2020)